Congenital aniridia: European COST action ANIRIDIA-NET guidelines for diagnosis, management and care.
Romano Davide, Romano Vito, Daruich Alejandra, Ferrari Giulio, Robert Matthieu, Semeraro Francesco, Lagali Neil, Bremond-Gignac Dominique
AI Summary
European ANIRIDIA-NET created guidelines for congenital aniridia diagnosis, management, and care, offering a comprehensive resource to improve patient outcomes for this complex, rare ocular disorder.
Abstract
Congenital aniridia is a rare ocular disorder affecting the majority of eye structures and can be associated with systemic manifestations. The main visible phenotypic characteristic is the partial or complete absence of the iris; however, foveal hypoplasia is a more frequent and reliable clinical sign. Other ocular comorbidities are associated with the disease, such as cataract, keratopathy and optic nerve hypoplasia. Mutation in the PAX6 gene is the most common cause of congenital aniridia, but other causative mutations exist. The main ocular symptoms experienced by those with congenital aniridia are photophobia, glare, low visual acuity, dryness/irritation of the ocular surface and nystagmus. Management and follow-up of patients with congenital aniridia can be challenging due to the lack of effective therapeutic options and the complexity of ocular manifestations and outcomes. These guidelines for the diagnosis, management and care of congenital aniridia have been developed at the European level, thanks to ANIRIDIA-NET, based on a review of the scientific literature on clinical and molecular characterization, therapeutic options as well as non-medical approaches.
MeSH Terms
Shields Classification
Key Concepts6
European COST action ANIRIDIA-NET developed guidelines for the diagnosis, management, and care of congenital aniridia based on a review of scientific literature covering clinical and molecular characterization, therapeutic options, and non-medical approaches.
Congenital aniridia is a rare ocular disorder affecting the majority of eye structures and can be associated with systemic manifestations.
The main visible phenotypic characteristic of congenital aniridia is the partial or complete absence of the iris; however, foveal hypoplasia is a more frequent and reliable clinical sign.
Other ocular comorbidities associated with congenital aniridia include cataract, keratopathy, and optic nerve hypoplasia.
Mutation in the PAX6 gene is the most common cause of congenital aniridia, but other causative mutations exist.
The main ocular symptoms experienced by those with congenital aniridia are photophobia, glare, low visual acuity, dryness/irritation of the ocular surface, and nystagmus.
Related Articles5
Congenital aniridia - A comprehensive review of clinical features and therapeutic approaches.
ReviewThe Effect of Metagenomic Sequencing on Patient Clinical Outcomes for Intraocular Infections: A Multicenter Randomized Controlled Trial.
Randomized Controlled TrialMulti-Omics Integration With Machine Learning Identified Early Diabetic Retinopathy, Diabetic Macula Edema and Anti-VEGF Treatment Response.
Observational StudyPredictors of Final Visual Outcome in Patients With Leber Hereditary Optic Neuropathy Treated With Lenadogene Nolparvovec Gene Therapy.
Clinical TrialPerimacular Atrophy Following Voretigene Neparvovec-Rzyl Treatment in the Setting of Previous Contralateral Eye Treatment With a Different Viral Vector.
Case SeriesIs this article assigned to the wrong chapter(s)? Let us know.